ARTICLE I AMENDMENTSPolymedica Corp • September 13th, 2006 • Pharmaceutical preparations • New York
Exhibit 1.1 CELGENE CORPORATION (a Delaware corporation) 20,000,000 Shares of Common Stock (Par Value $0.01 Per Share) UNDERWRITING AGREEMENTCelgene Corp /De/ • November 6th, 2006 • Pharmaceutical preparations • New York
EXHIBIT 10.2 MEDICAL DISCOVERIES, INC. SHARES OF SERIES A CONVERTIBLE PREFERRED STOCK AND COMMON STOCK WARRANTS SUBSCRIPTION AGREEMENTMedical Discoveries Inc • June 2nd, 2005 • Pharmaceutical preparations • California
EXHIBIT 10.1 (Date) (Name) (Address) Dear __________: The purpose of this letter agreement is to document the terms of the severance package to which you will be entitled should your employment with Ligand Pharmaceuticals Incorporated (the "Company")...Ligand Pharmaceuticals Inc • August 30th, 2006 • Pharmaceutical preparations
DEERFIELD CAPITAL, L.P.Nitromed Inc • January 29th, 2009 • Pharmaceutical preparations
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of NitroMed, Inc. and that this Agreement be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.
Exhibit 10.87 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, effective as of January 1, 2006, between Vyteris Holdings (Nevada), Inc., a Nevada corporation (the "Company"), and Timothy McIntyre ("Employee"). WHEREAS, the Company desires to employ Employee...Employment Agreement • March 30th, 2006 • Vyteris Holdings (Nevada), Inc. • Pharmaceutical preparations • New Jersey
EXHIBIT BRegistration Rights Agreement • May 28th, 2008 • China Pharma Holdings, Inc. • Pharmaceutical preparations • New York
THE ELIGIBLE SUBSIDIARIES REFERRED TO HEREIN, AS BORROWERSCredit Agreement • April 4th, 2006 • Allergan Inc • Pharmaceutical preparations • New York
Exhibit 10.10 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this "Agreement") is made effective as of this 15TH day of February, 2005 (the "Effective Date"), by and between ImmuneRegen BioSciences, Inc., a Delaware corporation (the "Company"), and...Employment Agreement • May 2nd, 2005 • Ir Biosciences Holdings Inc • Pharmaceutical preparations • Arizona
ARTICLE 2 REPRESENTATIONS AND WARRANTIES OF SELLERStock Purchase Agreement • April 18th, 2005 • DU Deli • Pharmaceutical preparations • Nevada
INDENTURE BETWEENIndenture • September 6th, 2005 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations
Page ---- EXHIBIT A Agreement of Reporting Persons 18Oak Management Corp • February 13th, 1997 • Pharmaceutical preparations
Each of the undersigned hereby agrees that the Schedule 13G filed on the date hereof with respect to the shares of Common Stock of ViroPharma Incorporated has been filed on behalf of the undersigned.
SUBLEASELease Agreement • July 25th, 2006 • Macrochem Corp • Pharmaceutical preparations • Massachusetts
EMPLOYMENT AGREEMENT -------------------- EMPLOYMENT AGREEMENT, effective as of April 1, 2006, between Vyteris Holdings (Nevada), Inc., a Nevada corporation (the "Company"), and Patrick McKiernan ("Employee"). WHEREAS, the Company desires to employ...Employment Agreement • May 23rd, 2006 • Vyteris Holdings (Nevada), Inc. • Pharmaceutical preparations • New Jersey
EXHIBIT 10.23 ___________________________ ___________________________ Name of Subscriber Memorandum No. SUBSCRIPTION AGREEMENT AND INVESTOR QUESTIONNAIRE IMARX THERAPEUTICS, INC. Common Stock Private Offering OFFERING PRICE $3.00 PER SHARE THE SHARES...Imarx Therapeutics Inc • May 4th, 2007 • Pharmaceutical preparations
EX-10.10 CONSULTING AGREEMENT This Agreement is made and entered into as of the 27th day of December, 2004 by and between Gabriele M. Cerrone ("Consultant") and Callisto Pharmaceuticals, Inc. (the "Company"). WHEREAS, the Consultant is a founder of...Consulting Agreement • March 30th, 2005 • Callisto Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 10.11 THIS AGREEMENT is made the 10th day of March 2004 B E T W E E N: (1) SHIRE PHARMACEUTICALS GROUP PLC (registered number 2883758) a company incorporated in and under the laws of England and Wales and having its registered office at...Agreement • March 12th, 2004 • Shire Pharmaceuticals Group PLC • Pharmaceutical preparations • England
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT ----------------------------- THIS SECURITIES PURCHASE AGREEMENT (this "Agreement") dated as of July 28, 2004, by and among PROVECTUS PHARMACEUTICALS, INC., a Nevada corporation (the "Company"), and the...Escrow Agreement • October 7th, 2004 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
AMONGPurchase Agreement • August 5th, 2003 • Nbty Inc • Pharmaceutical preparations • New York
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION...Elite Pharmaceuticals Inc /De/ • September 16th, 2008 • Pharmaceutical preparations
COMMON STOCK PURCHASE WARRANT FIRST WAVE BIOPHARMA, INC.First Wave BioPharma, Inc. • March 5th, 2024 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March __, 2024 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March ________, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from First Wave BioPharma, Inc. a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
by and among EPIMMUNE INC., HELENE PLOIX, as the Shareholder Representative, and theVoting Agreement • March 18th, 2005 • Epimmune Inc • Pharmaceutical preparations • Delaware
EXHIBIT AA PLEDGE AGREEMENT GRANTED BY: P.P. LUXCO HOLDINGS II S.A.R.L., a corporation constituted under the laws of Luxembourg, registered with the register of commerce and companies under number B 88.549 and having its registered office at 20 avenue...Pledge Agreement • January 30th, 2006 • Neurochem Inc • Pharmaceutical preparations • Quebec
Exhibit 10.1 IR BIOSCIENCES HOLDINGS, INC. SUBSCRIPTION AGREEMENT The undersigned (hereinafter "SUBSCRIBER" or "PURCHASER") hereby confirms his/her/its subscription for the purchase of units ("UNITS") of IR BioSciences Holdings, Inc., a Delaware...Subscription Agreement • December 7th, 2006 • Ir Biosciences Holdings Inc • Pharmaceutical preparations • New York
VIRBAC CORPORATION FORM 10-Q SEPTEMBER 30, 2003Stock Purchase Agreement • May 6th, 2005 • Virbac Corp • Pharmaceutical preparations • Delaware
RECITALSLoan and Security Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations • California
Exhibit 10.1 EMPLOYMENT AGREEMENT This Agreement, between Bradley Pharmaceuticals, Inc., a Delaware corporation with principal executive offices located at 383 Route 46 West, Fairfield, New Jersey 07004 (the "Company"), and Ralph Landau, Ph.D....Employment Agreement • October 30th, 2007 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
PART II AMENDMENTS TO CREDIT AGREEMENTCredit Agreement • April 1st, 2005 • Chattem Inc • Pharmaceutical preparations
1 EXHIBIT 10.38 AMENDMENT NO. 1 TO IFN-G DISTRIBUTION AGREEMENT This AMENDMENT NO. 1 ("Amendment") is entered into as of this the 4th day of April, 2000, by and between AMARILLO BIOSCIENCES, INC., a Texas corporation with its principal place of...Distribution Agreement • April 16th, 2001 • Amarillo Biosciences Inc • Pharmaceutical preparations
WITH [NAME OF EMPLOYEE] (EMPLOYEE COPY)Option Agreement • September 30th, 2005 • Predix Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Delaware
AMENDMENT TO THE PARTICIPATION AGREEMENT OF AUGUST 24, 1998 This Amendment to the Participation Agreement dated August 24, 1998 ("Amendment"), is entered into by and between: Ribozyme Pharmaceuticals Inc., a Delaware corporation ("Founder 1); Dr....Participation Agreement • June 16th, 1999 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations
andAgreement and Plan of Merger • October 30th, 2007 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 27th, 2024 • Qualigen Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of February 27, 2024, between Qualigen Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
EXECUTION VERSION AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • July 18th, 2008 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • Delaware
CONNETICS CORPORATION, as IssuerSupplemental Indenture • December 29th, 2006 • Connetics Corp • Pharmaceutical preparations • New York
